drugset / Trial / NCT00466856

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

NCT00466856

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors.

Timeline

Start
2003-12
Primary completion
2006-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Background Octreotide Peptide Intravenous